OMass Therapeutics raises £75 million series B from Sanofi Ventures, Northpond Ventures and GV. Health services Manufacturing Pharma Investments 26 April 2022 Share:
Round value (USD): 97.2m Round investors: GV Northpond Ventures Oxford Science Enterprises Sanofi Ventures Syncona Company: OMass Therapeutics Industry: Health services Manufacturing Pharma
Pheon Therapeutics raised $68M from Forbion and Brandon Capital. Biotech Health services Pharma Investments 19 September 2022
F2G raised $70 million in a financing round co-led by new investors Forbion and Sofinnova Partners Biotech Health services Pharma Investments 01 August 2022
Microbiotica in a £50M series B co-led by Flerie Invest and Tencent. Biotech Health services Manufacturing Investments 03 March 2022
Engitix in a $54M series A with DOMPE, Netherton Investments Biotech Health services Manufacturing Investments 09 January 2022
Aviado Bio raised $80 million series A led by New Enterprise Associates (NEA) and co-led by Monograph Capital Biotech Health services Manufacturing Pharma Investments 13 December 2021